glp 1 approved for prediabetes GLP−1 receptor agonists the treatment of obesity: Role as a promising approach What to know about the

Jorsal A, Kistorp C, Holmager P et al (2017) Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)a multicentre, double-blind, randomised, placebo-controlled trial

OHIP-14 K, 0.356) indicate residual selection/attrition bias and limited generalizability

The OD at 418 nm was measured in a microplate reader FLUOstar Omega provided by BMG LabTech (Ortenberg, Germany)

Vitamin B12 deficiency nerve damage may be relevant

References GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, et al